InflaRx
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.About IFRX
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab.
IFRX Key Statistics
Stock Snapshot
The current InflaRx(IFRX) stock price is $2.01, with a market capitalization of 296.95M. The stock trades at a price-to-earnings (P/E) ratio of -1.93.
On 2026-09-16, InflaRx(IFRX) stock traded between a low of $1.99 and a high of $2.17. Shares are currently priced at $2.01, which is +1.1% above the low and -7.1% below the high.
The InflaRx(IFRX)'s current trading volume is 578.5K, compared to an average daily volume of 534.91K.
During the past year, InflaRx(IFRX) stock moved between $0.80 at its lowest and $2.95 at its peak.
During the past year, InflaRx(IFRX) stock moved between $0.80 at its lowest and $2.95 at its peak.
IFRX News
Needham initiated coverage of InflaRx (IFRX) with a Buy rating and $8 price target InflaRx’s izicopan offers potentially significant upside in ANCA-associated v...
Analyst ratings
89%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.